First Community Trust NA Has $1.36 Million Stock Position in Hologic, Inc. (NASDAQ:HOLX)

First Community Trust NA lowered its position in Hologic, Inc. (NASDAQ:HOLXFree Report) by 1.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,760 shares of the medical equipment provider’s stock after selling 265 shares during the quarter. Hologic accounts for about 1.5% of First Community Trust NA’s holdings, making the stock its 15th largest position. First Community Trust NA’s holdings in Hologic were worth $1,357,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the company. GPS Wealth Strategies Group LLC acquired a new position in Hologic in the first quarter worth about $28,000. Sageworth Trust Co acquired a new position in shares of Hologic in the 1st quarter worth approximately $34,000. Clear Street Markets LLC lifted its position in shares of Hologic by 91.3% during the 1st quarter. Clear Street Markets LLC now owns 484 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 231 shares during the period. Salem Investment Counselors Inc. boosted its stake in Hologic by 163.9% in the 2nd quarter. Salem Investment Counselors Inc. now owns 549 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 341 shares in the last quarter. Finally, Whittier Trust Co. grew its position in Hologic by 55.5% in the first quarter. Whittier Trust Co. now owns 591 shares of the medical equipment provider’s stock valued at $48,000 after acquiring an additional 211 shares during the period. Institutional investors and hedge funds own 92.64% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on HOLX shares. Royal Bank of Canada cut their price target on shares of Hologic from $87.00 to $85.00 and set a “sector perform” rating for the company in a report on Tuesday, August 1st. Bank of America dropped their price target on Hologic from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Tuesday, August 1st. Raymond James reduced their price objective on Hologic from $100.00 to $95.00 and set an “outperform” rating on the stock in a research note on Tuesday, August 1st. Needham & Company LLC restated a “buy” rating and issued a $95.00 target price on shares of Hologic in a research note on Tuesday, August 1st. Finally, TheStreet downgraded shares of Hologic from a “b” rating to a “c+” rating in a research report on Monday, July 31st. Six research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, Hologic has an average rating of “Moderate Buy” and an average target price of $88.92.

Check Out Our Latest Research Report on HOLX

Hologic Trading Down 0.3 %

Shares of NASDAQ HOLX traded down $0.20 during midday trading on Friday, reaching $72.15. 344,956 shares of the stock were exchanged, compared to its average volume of 1,586,897. Hologic, Inc. has a 12 month low of $59.78 and a 12 month high of $87.88. The company has a debt-to-equity ratio of 0.54, a current ratio of 4.42 and a quick ratio of 3.73. The company has a market capitalization of $17.67 billion, a price-to-earnings ratio of 37.49 and a beta of 1.01. The business has a 50-day simple moving average of $76.46 and a two-hundred day simple moving average of $79.36.

Hologic (NASDAQ:HOLXGet Free Report) last announced its quarterly earnings results on Monday, July 31st. The medical equipment provider reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.04. Hologic had a net margin of 11.99% and a return on equity of 19.02%. The firm had revenue of $984.40 million for the quarter, compared to analyst estimates of $960.22 million. During the same quarter in the previous year, the firm posted $0.95 earnings per share. The business’s revenue was down 1.8% on a year-over-year basis. As a group, equities research analysts expect that Hologic, Inc. will post 3.92 EPS for the current year.

Hologic Profile

(Free Report)

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.

See Also

Want to see what other hedge funds are holding HOLX? Visit to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLXFree Report).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with's FREE daily email newsletter.